ARTIVA BIOTHERAPEUTICS
Artiva Biotherapeutics is a private biotech company advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, for the treatment of hematologic cancers or solid tumors. It was founded on the understanding that NK cells hold enormous therapeutic potential as cancer therapies and the dedication and expertise to overcome technological barriers in the scaling and manufacturing of these cells. At Artiva, its mission is to deliver highly effective cell therapies that are also safe and immediately available and accessible to any cancer patient who stands to benefit. Artiva’s platform delivers scalability, quality, and cryopreservation to support a pipeline of safe, effective, versatile, and accessible product candidates.
ARTIVA BIOTHERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2019-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.artivabio.com
Total Employee:
11+
Status:
Active
Contact:
858-267-4467
Email Addresses:
[email protected]
Total Funding:
198 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins
Similar Organizations
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Current Advisors List
Current Employees Featured
Founder
Investors List
Wellington Management
Wellington Management investment in Series B - Artiva Biotherapeutics
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Artiva Biotherapeutics
5AM Ventures
5AM Ventures investment in Series B - Artiva Biotherapeutics
Surveyor Capital
Surveyor Capital investment in Series B - Artiva Biotherapeutics
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series B - Artiva Biotherapeutics
Acuta Capital Partners
Acuta Capital Partners investment in Series B - Artiva Biotherapeutics
Franklin Templeton Investments
Franklin Templeton Investments investment in Series B - Artiva Biotherapeutics
EcoR1 Capital
EcoR1 Capital investment in Series B - Artiva Biotherapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Artiva Biotherapeutics
Green Cross Holding Corp
Green Cross Holding Corp investment in Series B - Artiva Biotherapeutics
Key Employee Changes
Official Site Inspections
http://www.artivabio.com Semrush global rank: 3.26 M Semrush visits lastest month: 5.06 K
- Host name: 220.252.71.34.bc.googleusercontent.com
- IP address: 34.71.252.220
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
